4E-BP1 regulates the sensitivity of human glioma cells to chemotherapy through PI3K/Akt/mTOR-independent pathway

Neuropathology : Official Journal of the Japanese Society of Neuropathology
Hui-Li ZhuXue-Yun Zhong

Abstract

Drug resistance is one of the most formidable obstacles for treatment of glioma. Eukaryotic initiation factor 4E-binding protein (4E-BP1), a key component in the rate-limiting step of protein translation initiation, is closely associated with poor prognosis in multiple tumor types. However, it is unclear whether 4E-BP1 is involved in the drug resistance of human glioma. Herein we show that the expression of 4E-BP1 in human SWOZ2-BCNU drug-resistant glioma cells is significantly lower than that of the parent SWOZ2 cell line. Moreover, down-regulation of 4E-BP1 by short interfering RNA significantly impaired the sensitivity of SWOZ2 and U251 cells to carmustine (BCNU). Furthermore, overexpression of 4E-BP1 with plasmid transfection regained this sensitivity. Clinical studies showed that the expression levels of 4E-BP1 in primary glioma tissues were markedly higher than those of recrudescent glioma tissues. Taken together, our results suggest that 4E-BP1 is a novel protein that contributes to acquired drug resistance and it may be a potential target for reversing drug resistance in human glioma.

References

May 13, 1993·Nature·H A LaneG Thomas
Feb 6, 1996·Proceedings of the National Academy of Sciences of the United States of America·D RousseauN Sonenberg
Nov 24, 1999·British Journal of Neurosurgery·D AfraD Vitanovics
Apr 28, 2000·The International Journal of Biochemistry & Cell Biology·M E MartínJ L Fando
Mar 6, 2003·The Journal of Biological Chemistry·Malvyne Rolli-DerkinderenMichel Dy
May 4, 2004·Nature Reviews. Molecular Cell Biology·Mathew L ColemanMichael F Olson
Mar 11, 2005·The New England Journal of Medicine·Monika E HegiRoger Stupp
Apr 2, 2005·Nature Reviews. Cancer·Michael DeanSusan Bates
Jun 9, 2006·Expert Review of Anticancer Therapy·Florence LefrancRobert Kiss
Aug 11, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·John P FruehaufRicardo Parker
Jan 4, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Federico RojoSantiago Ramon y Cajal
Apr 20, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Roger Stupp, Monika E Hegi
Sep 22, 2007·Journal of Controlled Release : Official Journal of the Controlled Release Society·Grace Y KimMichael J Cima
Oct 1, 2008·Cancer Letters·Ka Ho TamRonnie T P Poon
Apr 2, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Kathryn E O'ReillyIman Osman
Jun 14, 2012·Histopathology·Penelope KorkolopoulouAngelica A Saetta
Jan 24, 2013·Cancer Letters·Tetsuo NishiYasuhiro Kodera
May 30, 2013·Neuropathology : Official Journal of the Japanese Society of Neuropathology·Chao WangXueyun Zhong

❮ Previous
Next ❯

Related Concepts

Related Feeds

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.